Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the scientific sessions of the American College of Cardiology, 2001

European Journal of Heart Failure

Volumn 3, Issue 3, 2001, Pages 381-387

  Loui, A ^a   Cleland J G F, ^a   Crabbe, S ^a   Ford, S ^a   Thackray, S ^a   Houghton, T ^a   Clark, A ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Capricorn; Copernicus; Heart failure; Miracle; Recover; Renaissnace; Ritz 2; Staf

Indexed keywords

CARVEDILOL; CHOLESTEROL; ENDOTHELIN RECEPTOR ANTAGONIST; ETANERCEPT;

BODY FAT; CACHEXIA; CARDIOVERSION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ATRIAL FIBRILLATION; CACHEXIA; CARBAZOLES; CARBOXYLIC ACIDS; CHOLESTEROL; CYTOKINES; ENDOTHELINS; HEART FAILURE, CONGESTIVE; HUMANS; INDANS; INJECTIONS, INTRAVENOUS; MYOCARDIAL INFARCTION; PROPANOLAMINES; PYRIDINES; TETRAZOLES; UNITED STATES; VASODILATOR AGENTS;

EID: 0034831901     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00149-0     Document Type: Conference Paper

References (22)

1. Clinical trials update. IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II and APRICOT
2. Clinical Trial updates: Highlights of the scientific sessions of the American Heart Association year 200: Val HeFT COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, VMAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure
3. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II)
4. Design and methodology of the CAPRICORN trial - A randomised double-blind, placebo-controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dsyfunction after myocardial infarction
5. Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials
6. Long term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: A systematic overview of data from individual patients
7. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay
8. Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe congestive cardiac failure
9. Design and methodology of the CARE-HF trial. A randomised trial of cardiac resynchronisation in patients with heart failure and ventricular dyssynchrony
10. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial
11. Atrial fibrillation follow-up investigation of rhythm management-the AFFIRM Study design
12. Atrial fibrillation follow-up investigation of rhythm management - The AFFIRM study design
13. Endothelin antagonists for chronic heart failure: Do they have a role?
14. Update of REACH-1 and MERITHF clinical trials in heart failure
15. Body mass index, obesity, and cachexia vs survival in chronic heart failure: Results from the ELITE-II study
16. Serum total cholesterol, high density lipoprotein, and prognosis in patients with chronic heart failure
17. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
18. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
19. Effect of coenzyme Q-10 therapy in patients with congestive heart failure: A long-term multicenter randomized study
20. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure
21. Meeting report - The LIDO, HOPE, MOXCON and WASH studies
22. The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)